Israel Englander’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Israel Englander’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-343,595	Closed	-$622K	–	6796
2023 Q2	$622K	Buy	343,595 +202,554	+144%	+$370K	﹤0.01%	4391
2023 Q1	$186K	Buy	141,041 +91,032	+182%	+$149K	﹤0.01%	5202
2022 Q4	$85K	Buy	50,009 +9,228	+23%	+$11.7K	﹤0.01%	5633
2022 Q3	$75K	Sell	40,781 -40,046	-50%	-$119K	﹤0.01%	6062
2022 Q2	$248K	Sell	80,827 -164,341	-67%	-$1M	﹤0.01%	5516
2022 Q1	$1.77M	Buy	245,168 +10,770	+5%	+$106K	﹤0.01%	4003
2021 Q4	$3.84M	Sell	234,398 -277,485	-54%	-$3.23M	﹤0.01%	3163
2021 Q3	$5.09M	Sell	511,883 -10,620	-2%	-$106K	﹤0.01%	2836
2021 Q2	$5.21M	Buy	522,503 +47,503	+10%	+$477K	﹤0.01%	2698
2021 Q1	$4.73M	Buy	+475,000	New	+$4.91M	﹤0.01%	2627

Other funds holding PRDS

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Israel Englander's PRDS Position: Q3 2023 in Review

Israel Englander sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 343,595 shares — an estimated $622K sold.

Israel Englander first reported a position in PRDS in Q1 2021 and held it in 10 quarters. The position peaked at $5.21M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Israel Englander reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Israel Englander sold 343,595 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $622K.
Israel Englander first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Israel Englander's Pardes Biosciences, Inc. Common Stock position peaked at $5.21M in Q2 2021.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.